Bicara Therapeutics Inc. Common Stock ( BCAX) - Stock Earnings
BCAX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
BCAX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -27.4 million USD | — USD |
| 2025Q3 | -36.3 million USD | — USD |
| 2025Q4 | -37.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BCAX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.0 million USD | — USD |
| 2024 | -68.0 million USD | — USD |
| 2025 | -138.0 million USD | — USD |
| 2026 Est. | — | — |
BCAX
Price: $17.41
52 week price:
Earnings Per Share: 5.38 USD
P/E Ratio: 3.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 billion